AEMD

About AEMD

Aethlon Medical, Inc. (Aethlon) is a biotechnology company. The Company is focused on developing products to diagnose and treat life and organ-threatening diseases. It is involved in developing the Hemopurifier, a therapeutic blood filtration system indicated for infectious diseases and cancer. The Company operates through two segments: Aethlon and ESI. The Aethlon segment represents its therapeutic business activities. The ESI segment represents its diagnostic business. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression, seeding the spread of metastasis. The Company is conducting clinical trials in patients with advanced and metastatic head and neck cancer. It is focused on the treatment of solid tumors that are being treated with checkpoint inhibitors. Hemopurifier have been used to treat individuals infected with human immunodeficiency virus (HIV), hepatitis C virus (HCV), and Ebola.